Caroline Germa Selected Research

Letrozole (Femara)

2/2018	Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.
1/2018	Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
1/2018	Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
11/2016	Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caroline Germa Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 02/2018 - 12/2013
4	Neoplasms (Cancer) 01/2020 - 10/2003
3	Disease Progression 01/2020 - 01/2018
2	Diarrhea 01/2018 - 11/2014
2	Neutropenia 01/2018 - 11/2016
1	Alopecia (Baldness) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Vomiting 01/2018
1	Anemia 01/2018
1	Fatigue 01/2018
1	Nausea 01/2018
1	Leukopenia 11/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2005

Drug/Important Bio-Agent (IBA)

5	ribociclibIBA 02/2018 - 11/2016
4	Letrozole (Femara)FDA LinkGeneric 02/2018 - 11/2016
3	Hormones (Hormone)IBA 01/2018 - 11/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018 - 11/2016
2	human ERBB2 proteinIBA 11/2016 - 11/2014
2	Lapatinib (GW572016)FDA Link 11/2014 - 12/2013
2	neratinibIBA 11/2014 - 12/2013
2	Capecitabine (Xeloda)FDA Link 11/2014 - 12/2013
2	Trastuzumab (Herceptin)FDA Link 11/2014 - 12/2013
1	durvalumabIBA 01/2020
1	Cyclin-Dependent Kinase 4IBA 01/2018
1	Aromatase InhibitorsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	AlpelisibIBA 01/2016
1	NVP-BKM120IBA 01/2016
1	MTOR InhibitorsIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 11/2014
1	Tyrosine Kinase InhibitorsIBA 11/2014
1	Pharmaceutical PreparationsIBA 11/2014
1	Epidermal Growth Factor (EGF)IBA 12/2013
1	Gemcitabine FDA Link 03/2005
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2003

Therapy/Procedure

7	Therapeutics 01/2020 - 12/2013
1	Retreatment 01/2020
1	Aftercare (After-Treatment) 01/2018
1	Drug Therapy (Chemotherapy) 03/2005
1	Intravenous Infusions 10/2003